Initially, germline RUNX1 variants were classified as pathogenic if associated with FPD‐MM phenotype, but the discovery of new variants in cancer patients with no history of thrombocytopenia or familial haematological diseases is questioning this assertion. The gene discussed is RUNX1; the disease is Thrombocytopenia.